Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 5, 2024 4:00 P.M.
Form:
S-3
CIK:
0001534120
Company Name:
Avalo Therapeutics, Inc.
File Number:
333-279992